BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 3780030)

  • 1. Growth curves for height in Noonan syndrome.
    Witt DR; Keena BA; Hall JG; Allanson JE
    Clin Genet; 1986 Sep; 30(3):150-3. PubMed ID: 3780030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal defects and bone metabolism in Noonan, Costello and cardio-facio-cutaneous syndromes.
    Papadopoulou A; Bountouvi E
    Front Endocrinol (Lausanne); 2023; 14():1231828. PubMed ID: 37964950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth Hormone Treatment for Non-GHD Disorders: Excitement Tempered by Biology.
    Grimberg A; Hawkes CP
    J Clin Endocrinol Metab; 2024 Jan; 109(2):e442-e454. PubMed ID: 37450564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated growth assessment in the first 1000 d of life: an interdisciplinary conceptual framework.
    Nel S; Pattinson RC; Vannevel V; Feucht UD; Mulol H; Wenhold FA
    Public Health Nutr; 2023 Aug; 26(8):1523-1538. PubMed ID: 37170908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic conditions of short stature: A review of three classic examples.
    Butler MG; Miller BS; Romano A; Ross J; Abuzzahab MJ; Backeljauw P; Bamba V; Bhangoo A; Mauras N; Geffner M
    Front Endocrinol (Lausanne); 2022; 13():1011960. PubMed ID: 36339399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth, Endocrine Features, and Growth Hormone Treatment in Noonan Syndrome.
    Dahlgren J; Noordam C
    J Clin Med; 2022 Apr; 11(7):. PubMed ID: 35407641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth in Children With Noonan Syndrome and Effects of Growth Hormone Treatment on Adult Height.
    Libraro A; D'Ascanio V; Cappa M; Chiarito M; Digilio MC; Einaudi S; Grandone A; Maghnie M; Mazzanti L; Mussa A; Patti G; Scarano E; Spinuzza A; Vannelli S; Wasniewska MG; Ferrero GB; Faienza MF
    Front Endocrinol (Lausanne); 2021; 12():761171. PubMed ID: 35002956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Growth and Growth Hormone: From Antiquity to the Recominant Age to the Future.
    Graber E; Reiter EO; Rogol AD
    Front Endocrinol (Lausanne); 2021; 12():709936. PubMed ID: 34290673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of effectiveness of growth hormone therapy according to disease-causing genes in children with Noonan syndrome.
    Jo KJ; Kim YM; Yoon JY; Lee YJ; Han YM; Yoo HW; Kim HS; Cheon CK
    Korean J Pediatr; 2019 Jul; 62(7):274-280. PubMed ID: 30514065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of disease-specific growth charts in Turner syndrome and Noonan syndrome.
    Isojima T; Yokoya S
    Ann Pediatr Endocrinol Metab; 2017 Dec; 22(4):240-246. PubMed ID: 29301184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth references for Japanese individuals with Noonan syndrome.
    Isojima T; Sakazume S; Hasegawa T; Ogata T; Nakanishi T; Nagai T; Yokoya S
    Pediatr Res; 2016 Apr; 79(4):543-8. PubMed ID: 26650342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National growth charts for United Arab Emirates children with Down syndrome from birth to 15 years of age.
    Aburawi EH; Nagelkerke N; Deeb A; Abdulla S; Abdulrazzaq YM
    J Epidemiol; 2015; 25(1):20-9. PubMed ID: 25196167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth failure and outcome in Rett syndrome: specific growth references.
    Tarquinio DC; Motil KJ; Hou W; Lee HS; Glaze DG; Skinner SA; Neul JL; Annese F; McNair L; Barrish JO; Geerts SP; Lane JB; Percy AK
    Neurology; 2012 Oct; 79(16):1653-61. PubMed ID: 23035069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noonan syndrome: clinical aspects and molecular pathogenesis.
    Tartaglia M; Zampino G; Gelb BD
    Mol Syndromol; 2010 Feb; 1(1):2-26. PubMed ID: 20648242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The natural history of Noonan syndrome: a long-term follow-up study.
    Shaw AC; Kalidas K; Crosby AH; Jeffery S; Patton MA
    Arch Dis Child; 2007 Feb; 92(2):128-32. PubMed ID: 16990350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth charts for Down's syndrome from birth to 18 years of age.
    Myrelid A; Gustafsson J; Ollars B; Annerén G
    Arch Dis Child; 2002 Aug; 87(2):97-103. PubMed ID: 12138052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective growth hormone (GH) secretion and short-term treatment in Noonan syndrome.
    Soliman AT; Rajab A; el Zalabany M; alSalmi I; Fattah MA
    Indian J Pediatr; 1998; 65(5):741-9. PubMed ID: 10773931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth curves for Laron syndrome.
    Laron Z; Lilos P; Klinger B
    Arch Dis Child; 1993 Jun; 68(6):768-70. PubMed ID: 8333769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noonan syndrome: growth and clinical manifestations in 144 cases.
    Ranke MB; Heidemann P; Knupfer C; Enders H; Schmaltz AA; Bierich JR
    Eur J Pediatr; 1988 Dec; 148(3):220-7. PubMed ID: 3215198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical study of Noonan syndrome.
    Sharland M; Burch M; McKenna WM; Paton MA
    Arch Dis Child; 1992 Feb; 67(2):178-83. PubMed ID: 1543375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.